These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
352 related items for PubMed ID: 31340669
1. Formation and Resolution of Pial Microvascular Thrombosis in a Mouse Model of Thrombotic Thrombocytopenic Purpura. Adili R, Holinstat M. Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1817-1830. PubMed ID: 31340669 [Abstract] [Full Text] [Related]
2. Transfusion of Platelets Loaded With Recombinant ADAMTS13 (A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13) Is Efficacious for Inhibiting Arterial Thrombosis Associated With Thrombotic Thrombocytopenic Purpura. Abdelgawwad MS, Cao W, Zheng L, Kocher NK, Williams LA, Zheng XL. Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2731-2743. PubMed ID: 30354235 [Abstract] [Full Text] [Related]
15. A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13. Schiviz A, Wuersch K, Piskernik C, Dietrich B, Hoellriegl W, Rottensteiner H, Scheiflinger F, Schwarz HP, Muchitsch EM. Blood; 2012 Jun 21; 119(25):6128-35. PubMed ID: 22529289 [Abstract] [Full Text] [Related]
16. Pathophysiology of thrombotic thrombocytopenic purpura. Tsai HM. Int J Hematol; 2010 Jan 21; 91(1):1-19. PubMed ID: 20058209 [Abstract] [Full Text] [Related]
17. Loss of von Willebrand factor high-molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpura. Béranger N, Benghezal S, Savigny S, Capdenat S, Joly BS, Coppo P, Stepanian A, Veyradier A. Thromb Res; 2019 Sep 21; 181():29-35. PubMed ID: 31330376 [Abstract] [Full Text] [Related]